-
Fibrinogen and CFAH as putative biomarkers for Parkinson’s disease
-
Fine-Mapping Genetic Risk and Age at Onset Loci in Parkinson’s Disease
-
First Reported Experience of Dual Therapy With Deep Brain Stimulation and Foslevodopa/Foscarbidopa Subcutaneous Infusion
-
First-in-Human Single-Ascending-Dose Trial of ALN-SNCA, an Intrathecally Administered siRNA for Reducing α-synuclein, in Patients with Early-Stage Parkinson’s Disease
-
Five-Year Real-World Outcomes Of Botulinum Toxin Injections For Sialorrhoea In Parkinson’s
-
Five‑Year Outcomes Following Unilateral MR‑Guided Focused Ultrasound Pallidotomy in Parkinson’s Disease
-
Fluid Biomarker Signatures in Atypical Parkinsonian Syndromes: Insights into Neurodegeneration and Clinical Heterogeneity
-
Fluid Biomarkers and the 4R-Tauopathies
-
fMRI Activity during Working Memory Manipulation is Associated with Caudate Integrity in Early Parkinson’s Disease
-
Focused Ultrasound for Essential Tremor: Results After One Year
- « Previous Page
- 1
- …
- 85
- 86
- 87
- 88
- 89
- …
- 208
- Next Page »
